| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 20 |
| 1 | ALBUTEROL SULFATE | 18 |
| 2 | FLUTICASONE PROPIONATE AND SALMETEROL | 18 |
| 3 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 17 |
| 4 | ADALIMUMAB | 14 |
| 5 | APREPITANT | 14 |
| 6 | FLUOROURACIL | 14 |
| 7 | FLUOROURACIL CREAM, 0.5% | 14 |
| 8 | POLYETHYLENE GLYCOL 3350 | 14 |
| 9 | FOSAPREPITANT DIMEGLUMINE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OVINE DIGOXIN IMMUNE FAB | 1 | 0.0048 |
| 1 | NEOSTIGMINE METHYLSULFATE | 2 | 0.0046 |
| 2 | SODIUM ACETATE | 1 | 0.0035 |
| 3 | TECHNETIUM TC-99M | 2 | 0.0032 |
| 4 | FLUMAZENIL | 2 | 0.0023 |
| 5 | RITUXIMAB AND HYALURONIDASE | 1 | 0.0022 |
| 6 | APREPITANT | 14 | 0.0019 |
| 7 | OXYMETAZOLINE HCL | 1 | 0.0018 |
| 8 | PEGFILGRASTIM | 20 | 0.0017 |
| 9 | DINOPROSTONE | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 21 |
| 1 | Corticosteroid [EPC] | 19 |
| 2 | Osmotic Laxative [EPC] | 18 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 14 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 14 |
| 5 | Alkylating Drug [EPC] | 12 |
| 6 | Benzodiazepine [EPC] | 12 |
| 7 | Insulin Analog [EPC] | 12 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 12 |
| 9 | Insulin [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 14 | 0.0016 |
| 3 | Oxytocic [EPC] | 2 | 0.0007 |
| 4 | Radioactive Diagnostic Agent [EPC] | 2 | 0.0006 |
| 5 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 6 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 9 | Insulin [EPC] | 9 | 0.0002 |